An elevated VWF/ADAMTS13 ratio was shown to be independently associated with poor prognosis and mortality in patients with advanced non-small-cell lung cancer (NSCLC) [128]. This evidence concerns the gene ADAMTS13 and non-small cell lung carcinoma.